
Our pick · Oct 2026
Embody
from $49/mo
Compounded semaglutide · 12-month plan · $588 up front · checked Oct 27
- LegitScript certified
Our pick is a commercial choice. We may earn a commission when you join.
Coverage and access · NJ
We have no confirmed current GLP-1 rule for NJ FamilyCare, so we give you no verdict.
Ask your plan about your exact medicine, form and diagnosis before you pay. Use the checklist below.
This is information, not medical advice or a benefit decision.
7 programs that serve New Jersey publish a complete monthly price, from $49 at Embody to $299 at Willow.

Our pick · Oct 2026
from $49/mo
Compounded semaglutide · 12-month plan · $588 up front · checked Oct 27
Our pick is a commercial choice. We may earn a commission when you join.
Some programs are affiliate partners, and we may earn a commission if you join through our link. Payment never moves a row. How we rank

Compounded semaglutide · 12-mo prepay
$588 up front
Advertised program price, not an insurance copay.
Good: 7.6/10 · Compounded
Checked Oct 16, 2026; a rating claim didn't match Trustpilot.
$588 upfront for 12 months of semaglutide. Yearly-plan sale ends December 1; confirm renewal. Paid terms are normally non-refundable; provider-determined medical disqualification allows a refund for the unused term, less services already provided.
The October 27–December 1, 2026 sale offers semaglutide at $49/month equivalent ($588 prepaid for twelve months) and tirzepatide at $99/month equivalent ($1,188 prepaid). One-month plans remain $79 and $129. The published terms say the rate stays fixed on the selected plan. Confirm the renewal amount and date before paying; these sale rates are not month-to-month bills.
We checked this price on Oct 27, 2026.
Full review and sources
12-mo prepay
$1,188 up front
Advertised program price, not an insurance copay.
Fair: 7.3/10 · Compounded
Checked Jul 18, 2026; few independent reviews yet.
$1,188 paid once for the 12-month semaglutide plan; does not renew. Separate monthly subscription: $99 first, then $165. Confirm how four-week vial supplies cover the billing term.
12-month semaglutide one-time plan: $1,188 paid up front, with no renewal. Separate monthly Subscribe and Save is $99 for the first month, then $165. Product pages describe four-week vials; confirm supply coverage across the selected billing term.
We checked this price on Sep 3, 2026.
Full review and sources
Compounded semaglutide · 12-mo prepay
$1,188 up front
Advertised program price, not an insurance copay.
Good: 7.8/10 · Compounded
Checked Oct 16, 2026; a rating claim didn't match Trustpilot.
12-month compounded semaglutide plan: $1,188 billed every 12 months. The shortest plan is $149 every 4 weeks; plans renew until cancelled Compounded Semaglutide (12-month plan): $99 monthly equivalent; $1,188 billed every 12 months. Provider review, medication and shipping included; prescription required; treatment only if clinically appropriate. Checked October 5, 2026. Consultation: included. Shipping: free. The $99/mo semaglutide rate requires $1,188 upfront for 12 months; the shorter $149 plan bills every 4 weeks, not once per calendar month
We checked this price on Oct 5, 2026.
Full review and sources
Compounded semaglutide lozenge · auto-refill
Advertised program price, not an insurance copay.
Fair: 6.5/10 · Compounded
Checked Oct 16, 2026.
as low as, auto-refill
We checked this price on Oct 2, 2026.
Full review and sources$99/mo equivalent at Trimi Health
12-mo prepay
$1,188 up front
Advertised program price, not an insurance copay.
Good: 7.6/10 · Compounded
Checked Jul 2, 2026.
$1,188 upfront for 12 months; applicable taxes may add to the bill 12-month prepay: $1,188 upfront ($99 monthly equivalent); does not auto-renew. The separate month-to-month semaglutide plan is $175
We checked this price on Oct 20, 2026.
Full review and sourcesfrom$297/mo at Direct Meds GLP-1

Confirm the full bill
Advertised program price, not an insurance copay.
Good: 7.5/10 · Compounded
Checked Oct 16, 2026.
Confirm the current prescribed treatment and full bill with the provider.
We checked this price on Sep 3, 2026.
Full review and sourcesConfirm the full bill
Advertised program price, not an insurance copay.
Good: 7.6/10 · Compounded
Checked Oct 16, 2026; a rating claim didn't match Trustpilot.
$299/mo is a starting program price, not one rate for every product. Willow's current help center pricing article lists compounded semaglutide injections at $299/mo up to 3.5 mg and $399/mo at 7 mg, tirzepatide injections at $399/mo through 6.375 mg then $499/mo at 8.5 and 11 mg, $524/mo at 13.5 mg and $549/mo at 17 mg, semaglutide tablets at $299/mo for all listed dosages, and tirzepatide tablets at $399/mo at 6 and 10 mg and $459/mo at 20 mg. Public price schedule checked September 26, 2026; confirm the prescribed product and current quote. Compounded Semaglutide (injectable): Covers medication, consultations, shipping and dose adjustments. $299/mo holds to 3.5 mg, then $399/mo at 7 mg on the help center pricing article, verified 2026-09-03 Compounded Semaglutide (oral tablet, daily): Compounded daily dissolving tablet, $299/mo for all listed dosages in Willow's current help center price schedule. This is distinct from the injection's dose ladder and is not FDA-approved Wegovy. Price checked September 26, 2026. Consultation: included. Shipping: free. The reviewed catalogue lists compounded products; a current brand-name Wegovy or Zepbound offer did not appear there
We checked this price on Sep 26, 2026.
Full review and sources3 more programs serve New Jersey without one complete monthly price: Collective, Maximus and Wellorithm. Compare their terms in the price index.
We left out 30 programs whose service-area list has a caveat for New Jersey or is incomplete, so confirm your address at intake.
A program that serves New Jersey still decides whether to prescribe. Before enrolling, confirm whether it accepts your Medicaid plan and whether your prescribed treatment is covered. The advertised cash prices are not insurance copays. Most listed programs sell compounded semaglutide or tirzepatide, which is not FDA-approved. Check a compounded provider before you pay.
We have not confirmed a current verdict, so use this as background and check with your plan.
NJ FamilyCare covers GLP-1 medicines only for FDA-approved uses other than weight loss, according to a September 2025 Department of Human Services report to the Legislature. The report gives Wegovy for cardiovascular disease and Zepbound for sleep apnea as examples, and it says some children may qualify through EPSDT, the Medicaid benefit for members under 21. The department wrote the report as a cost study for state fiscal year 2026, not a drug-by-drug authorization policy, and we did not find a current NJ FamilyCare criteria document. If you have NJ FamilyCare, ask your health plan for its current prior authorization criteria for your exact drug, diagnosis and age. We have not confirmed a current coverage verdict from these materials. Ask NJ FamilyCare or your managed-care plan for the policy that applies to your prescription today.
A drug on the preferred list is not covered for every use, so check the rule for yours. A weight-loss exclusion leaves diabetes and other medical requests to their own rules.
We read NJ Department of Human Services report: NJ FamilyCare coverage of weight loss drugs, September 2025 (fiscal year 2026 estimates) on October 15, 2026; it does not confirm today's rule.
Call your Medicaid plan, Medicare drug plan or private insurer with these questions, and keep the reference number for each call.
Before you pay cash, confirm:
An “insurance accepted” badge does not tell you your benefit, so ask your plan how its review works.
We have not confirmed NJ FamilyCare's current criteria, so ask your plan which form and records it wants before your prescriber files the request.
What your prescriber usually sends:
Your prescriber's office files the request; you cannot file it yourself. If NJ FamilyCare says no, ask for the reason in writing, because the notice tells you how to ask for a review and by when.
Medicare's GLP-1 Bridge follows federal rules in every state, so NJ FamilyCare's policy does not decide your Medicare benefit.
We checked CMS's Bridge guidance for Part D plans on September 26, 2026.
Two free official services can help you, and we earn no commission from either.
NJ FamilyCare covers GLP-1 medicines only for FDA-approved uses other than weight loss, according to a September 2025 Department of Human Services report to the Legislature.
The report gives Wegovy for cardiovascular disease and Zepbound for sleep apnea as examples, and it says some children may qualify through EPSDT, the Medicaid benefit for members under 21. The department wrote the report as a cost study for state fiscal year 2026, not a drug-by-drug authorization policy, and we did not find a current NJ FamilyCare criteria document. If you have NJ FamilyCare, ask your health plan for its current prior authorization criteria for your exact drug, diagnosis and age. We have not confirmed a current coverage verdict from these materials. Ask NJ FamilyCare or your managed-care plan for the policy that applies to your prescription today. Before you pay, confirm your exact drug, your diagnosis, any age rules and your plan's authorization steps.
Yes.
Medicare's GLP-1 Bridge follows federal eligibility rules in every state, not NJ FamilyCare's policy. Your ordinary Part D coverage depends on your prescription and your drug plan, and the Bridge runs its own eligibility and authorization review.
Yes, from 10 online programs that publish a service area including New Jersey.
At intake, confirm your address, the exact medication and any pharmacy limits, because a state listing does not guarantee you a prescription or a delivery date.
Among programs that serve New Jersey, the lowest complete monthly price we found is $49 at Embody.
Across the 9 compounded programs we track nationally, the median advertised recurring price is $99/mo, from $49 to $299. That national figure is not a measured New Jersey average, insurance copay or quote for your dose.
Affiliate partners we feature. We may earn a commission.
Check the medication, commitment and total price for your selected plan.
Affiliate links, we earn a commission at no extra cost to you. These are featured partners, prioritized by our affiliate economics, not an editorial "best" ranking. Published scores have different evidence limits and do not establish better care. See the program comparison and scoring limitations.